{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:45:29Z","timestamp":1790786729871,"version":"4.1.0"},"reference-count":18,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2019.3721","type":"journal-article","created":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T11:34:31Z","timestamp":1557488071000},"page":"e193721","source":"Crossref","is-referenced-by-count":94,"title":["Development and Validation of Machine Learning Models in Prediction of Remission in Patients With Moderate to Severe Crohn Disease"],"prefix":"10.1001","volume":"2","author":[{"given":"Akbar K.","family":"Waljee","sequence":"first","affiliation":[{"name":"Michigan Integrated Center for Health Analytics and Medical Prediction, Ann Arbor"},{"name":"VA Center for Clinical Management Research, VA Ann Arbor Health Care System, Ann Arbor, Michigan"},{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Michigan Medicine, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth I.","family":"Wallace","sequence":"additional","affiliation":[{"name":"Michigan Integrated Center for Health Analytics and Medical Prediction, Ann Arbor"},{"name":"VA Center for Clinical Management Research, VA Ann Arbor Health Care System, Ann Arbor, Michigan"},{"name":"Division of Rheumatology, Department of Internal Medicine, Michigan Medicine, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley","family":"Cohen-Mekelburg","sequence":"additional","affiliation":[{"name":"VA Center for Clinical Management Research, VA Ann Arbor Health Care System, Ann Arbor, Michigan"},{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Michigan Medicine, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Statistics, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Statistics, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay","family":"Sauder","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Michigan Medicine, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan W.","family":"Stidham","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Michigan Medicine, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Statistics, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D. R.","family":"Higgins","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Michigan Medicine, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2019,5,10]]},"reference":[{"issue":"6","key":"zoi190165r1","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.cgh.2016.10.039","article-title":"Incidence and prevalence of Crohn\u2019s disease and ulcerative colitis in Olmsted County, Minnesota from 1970 through 2010.","volume":"15","author":"Shivashankar","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"zoi190165r2","article-title":"Biological therapies in inflammatory bowel disease: beyond anti-TNF therapies","author":"Katsanos","journal-title":"Clin Immunol"},{"issue":"3","key":"zoi190165r3","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.cgh.2014.07.029","article-title":"Levels of drug and antidrug antibodies are associated with outcome of interventions after loss of response to infliximab or adalimumab.","volume":"13","author":"Yanai","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"zoi190165r4","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/MIB.0000000000000202","article-title":"Role for therapeutic drug monitoring during induction therapy with TNF antagonists in IBD: evolution in the definition and management of primary nonresponse.","volume":"21","author":"Papamichael","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"zoi190165r5","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/ajg.2011.103","article-title":"Assessing response and loss of response to biological therapies in IBD.","volume":"106","author":"Yanai","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"zoi190165r6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00535-016-1283-0","article-title":"Emerging biologics in inflammatory bowel disease.","volume":"52","author":"Chan","year":"2017","journal-title":"J Gastroenterol"},{"issue":"20","key":"zoi190165r7","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1056\/NEJMoa1602773","article-title":"Ustekinumab as induction and maintenance therapy for Crohn\u2019s disease.","volume":"375","author":"Feagan","year":"2016","journal-title":"N Engl J Med"},{"issue":"6","key":"zoi190165r8","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/ibd\/izy031","article-title":"Predicting corticosteroid-free biologic remission with vedolizumab in Crohn\u2019s disease.","volume":"24","author":"Waljee","year":"2018","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"zoi190165r9","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/apt.14510","article-title":"Predicting corticosteroid-free endoscopic remission with vedolizumab in ulcerative colitis.","volume":"47","author":"Waljee","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"zoi190165r10","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1053\/j.gastro.2018.01.043","article-title":"Pharmacokinetics and exposure response relationships of ustekinumab in patients with Crohn\u2019s disease.","volume":"154","author":"Adedokun","year":"2018","journal-title":"Gastroenterology"},{"issue":"5","key":"zoi190165r12","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/j.1365-2036.2011.04987.x","article-title":"C-reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohn\u2019s disease: a post-hoc analysis from ACCENT I.","volume":"35","author":"Reinisch","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"zoi190165r13","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/ajg.2015.120","article-title":"C-reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: a systematic review and meta-analysis.","volume":"110","author":"Mosli","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"zoi190165r14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests.","volume":"45","author":"Breiman","year":"2001","journal-title":"Mach Learn"},{"issue":"3","key":"zoi190165r15","first-page":"18","article-title":"Classification and regression by random Forest.","volume":"2","author":"Liaw","year":"2002","journal-title":"R News"},{"issue":"5","key":"zoi190165r16","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1097\/00054725-200409000-00026","article-title":"C-reactive protein as a marker for inflammatory bowel disease.","volume":"10","author":"Vermeire","year":"2004","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"zoi190165r17","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11938-017-0129-z","article-title":"Utility of biomarkers in the management of inflammatory bowel disease.","volume":"15","author":"Kochhar","year":"2017","journal-title":"Curr Treat Options Gastroenterol"},{"key":"zoi190165r11","doi-asserted-by":"crossref","unstructured":"The YODA Project. https:\/\/yoda.yale.edu\/. Accessed November 6, 2018.","DOI":"10.21820\/23987073.2018.3.41"},{"key":"zoi190165r18","unstructured":"Metro Medical. Stelara 90MG\/1ML PFS each. https:\/\/www.metromedicalorder.com\/stelara-90mg-1ml-pfs-each.html. Accessed November 6, 2018."}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamanetworkopen\/article-pdf\/2\/5\/e193721\/17677131\/waljee_2019_oi_190165.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T17:06:47Z","timestamp":1663434407000},"score":1,"resource":{"primary":{"URL":"http:\/\/jamanetworkopen.jamanetwork.com\/article.aspx?doi=10.1001\/jamanetworkopen.2019.3721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,10]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.3721","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,10]]}}}